FOR PARTNERS
PharmaIN is actively seeking collaboration, licensing, and investment opportunities.
For more information, please send inquiries to:
- PRWeb: PharmaIN Unveils Interim Phase 1b Clinical Data on Activity and Safety of PHIN-214 in Decompensated Liver Cirrhosis at AASLD - The Liver Meeting 2024
- PRWeb: PharmaIN Announces Acceptance of Abstract for Poster Presentation at AASLD, The Liver Meeting 2024
- PRWeb: The Publication of Research in Science Translational Medicine Announcement
- PharmaIN and Shionogi Announcement